Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...

As word of his diagnosis spread, friends, neighbors, and even strangers wanted to help. A small committee of friends and ...

Life was good for Betsy Ehrenberg. It was 2017, and she was 68, a partner at Boston law firm Pyle Rome Ehrenberg PC. She represented unions in collective bargaining matters and workers who’d ...

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) offered an allogenic ...

Discover how preleukemic stem cells alter the bone marrow microenvironment, promoting leukemia growth. This study reveals key ...

When resistance to or failure of hypomethylating agents (HMAs) occurs in acute myeloid leukemia (AML), depleting a ligase ...

Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than ...

Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and PrECOG, LLC, will present a variety of abstracts that aim to improve treatments for patients with lymphoma and acute leukemias at ...

Mizuho Securities analyst Salim Syed has maintained their bullish stance on KURA stock, giving a Buy rating today. Salim Syed’s rating ...

A pioneering Finnish study has shown that drug sensitivity testing can help pinpoint which leukemia patients are likely to ...

A phase 2/3 study investigating uproleselan with standard 7+3 chemotherapy in newly diagnosed, older patients with acute ...

About Hemogenyx Pharmaceuticals plc Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and ...